These results suggest that induction of Smad7, thereby restoring the balance of TGF-beta/Smad signaling, may be a central mechanism by which AA inhibits liver fibrosis in vivo and in vitro. The gene discussed is SMAD7; the disease is Hepatic fibrosis.